Carnegie acted as sole manager in the secondary placing of 1.7 million shares in Clavis Pharma ASA, at a price of NOK 50.50 per share. The seller was MVM Life Science Partners LLP. Clavis Pharma ASA is an oncology focused pharmaceutical company.January, 2010.
Healthcare
Secondary placing of 1.7 million shares in Clavis Pharma ASA (NO) — NOK 84 million
January 2010